BGC
CVS icon

Beutel, Goodman & Co’s CVS Health CVS Stock Holding History

Beutel, Goodman & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62K Sell
600
-5,265
-90% -$470K ﹤0.01% 134
2026
Q1 		$421K Sell
5,865
-5,075
-46% -$391K ﹤0.01% 118
2025
Q4 		$868K Sell
10,940
-2,875
-21% -$227K 0.01% 107
2025
Q3 		$1.04M Sell
13,815
-1,825
-12% -$125K 0.01% 104
2025
Q2 		$1.08M Sell
15,640
-3,600
-19% -$236K 0.01% 101
2025
Q1 		$1.3M Buy
+19,240
New +$1.15M 0.01% 101

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Beutel, Goodman & Co's CVS Position: Q2 2026 in Review

Beutel, Goodman & Co reduced its CVS Health (CVS) stake by 90% in Q2 2026, selling an estimated $470K and leaving 600 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #134.

Beutel, Goodman & Co first reported a position in CVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.3M in Q1 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Beutel, Goodman & Co held 600 shares of CVS Health worth $62K as of Q2 2026.
  • Beutel, Goodman & Co sold 5,265 CVS Health shares in Q2 2026, an estimated $470K.
  • CVS Health made up ﹤0.01% of Beutel, Goodman & Co's portfolio in Q2 2026, its #134 holding.
  • Beutel, Goodman & Co first reported a position in CVS Health in Q1 2025 and has held it in 6 quarters since.
  • Beutel, Goodman & Co's CVS Health position peaked at $1.3M in Q1 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Beutel, Goodman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.